Set & SettingMedicinal Chemistry & Drug Development

On the Varieties of Conscious Experiences: Altered Beliefs Under Psychedelics (ALBUS)

This theory-building paper proposes the ALBUS (Altered Beliefs Under Psychedelics) model as an extension of the REBUS hypothesis, suggesting that 5-HT2A receptor activation can lead to both relaxation (REBUS) and strengthening (SEBUS) of beliefs depending on dosage and context. The authors draw parallels between psychedelic states and lucid dreaming, focusing on mechanisms of conscious perception, dreaming, and memory.

Authors

  • Matthew Johnson

Published

Neuroscience of Consciousness
meta Study

Abstract

How is it that psychedelics so profoundly impact brain and mind? According to the model of Relaxed Beliefs Under Psychedelics (REBUS), 5-HT2a agonism is thought to help relax prior expectations, thus making room for new perspectives and patterns. Here, we introduce an alternative (but largely compatible) perspective, proposing that REBUS effects may primarily correspond to a particular (but potentially pivotal) regime of very high levels of 5-HT2a receptor agonism. Depending on both a variety of contextual factors and the specific neural systems being considered, we suggest opposite effects may also occur in which synchronous neural activity becomes more powerful, with accompanying Strengthened Beliefs Under Psychedelics (SEBUS) effects. Such SEBUS effects are consistent with the enhanced meaning-making observed in psychedelic therapy (e.g. psychological insight and the noetic quality of mystical experiences), with the imposition of prior expectations on perception (e.g. hallucinations and pareidolia), and with the delusional thinking that sometimes occurs during psychedelic experiences (e.g. apophenia, paranoia, engendering of inaccurate interpretations of events, and potentially false memories). With Altered Beliefs Under Psychedelics (ALBUS), we propose that the manifestation of SEBUS vs. REBUS effects may vary across the dose-response curve of 5-HT2a signaling. While we explore a diverse range of sometimes complex models, our basic idea is fundamentally simple: psychedelic experiences can be understood as kinds of waking dream states of varying degrees of lucidity, with similar underlying mechanisms. We further demonstrate the utility of ALBUS by providing neurophenomenological models of psychedelics focusing on mechanisms of conscious perceptual synthesis, dreaming, and episodic memory and mental simulation.

Available with Blossom Pro

Research Summary of 'On the Varieties of Conscious Experiences: Altered Beliefs Under Psychedelics (ALBUS)'

Introduction

Earlier theorising about how classical psychedelics act on brain and mind has converged around predictive-processing accounts such as the Relaxed Beliefs Under Psychedelics (REBUS) model, which links 5-HT2a receptor agonism to a relaxation of high‑level priors and therefore greater influence of bottom‑up sensory evidence. At the same time, many phenomenological features of psychedelic experience—enhanced meaning, vivid imagery, pareidolia, hallucinations and sometimes delusional interpretations—are more naturally framed as cases in which prior expectations exert stronger influence over perception and cognition. Safron and colleagues situate these tensions within the broader “psychedelic renaissance” and argue that more nuanced, multiscale models are required if clinical translation and basic science are to proceed reliably. This paper introduces Altered Beliefs Under Psychedelics (ALBUS), a unifying conceptual framework that integrates REBUS with a complementary hypothesis termed Strengthened Beliefs Under Psychedelics (SEBUS). The authors propose that both relaxation and strengthening of beliefs can occur under 5-HT2a agonism depending on dose, neural subsystem, and contextual factors (including ‘‘set and setting’’), and they develop neurophenomenological and mechanistic models linking cortical microcircuits, oscillatory dynamics, hippocampal/entorhinal systems and modes of conscious perception to these opposing effects. ALBUS is presented as a hypothesis-generating synthesis that aims to explain a wide range of psychedelic phenomena—from waking dreaming and mystical noeticity to hallucinations and therapeutic insight—and to motivate specific empirical tests.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Pro members can view the original manuscript directly in the browser.

Study Details

References (29)

Papers cited by this study that are also in Blossom

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)

Pivotal Mental States

Brouwer, A., Carhart-Harris, R. L. · Journal of Psychopharmacology (2020)

The entropic brain - revisited

Carhart-Harris, R. L. · Neuropharmacology (2018)

Canalization and plasticity in psychopathology

Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E. et al. · Neuropharmacology (2023)

492 cited
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)

Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors

Carter, O., Burr, D. C., Pettigrew, J. D. et al. · Journal of Cognitive Neuroscience (2006)

Show all 29 references
Models of psychedelic drug action: modulation of cortical-subcortical circuits

Doss, M. K., Madden, M. B., Gaddis, A. et al. · Brain (2021)

Cellular rules underlying psychedelic control of prefrontal pyramidal neurons

Ekins, T. G., Brooks, I., Kailasa, S. et al. · Biorxiv (2023)

A narrative synthesis of research with 5-MeO-DMT

Ermakova, A. O., Dunbar, F., Rucker, J. et al. · Journal of Psychopharmacology (2021)

Updating the dynamic framework of thought: Creativity and psychedelics

Girn, M., Mills, C., Roseman, L. et al. · NeuroImage (2020)

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study

Hutten, N. R. P. W., Mason, N. L., Dolder, P. C. et al. · European Neuropsychopharmacology (2020)

95 cited
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)

Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison

Leptourgos, P., Fortier-Davy, M., Carhart-Harris, R. L. et al. · Schizophrenia Bulletin (2020)

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

Maclean, K. A., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2011)

An Integrated theory of false insights and beliefs under psychedelics

McGovern, H., Grimmer, H. J., Doss, M. K. et al. · Communications Psychology (2024)

Lower-dose psycholytic therapy - A neglected approach

Passie, T., Guss, J., Kraehenmann, R. · Frontiers in Psychiatry (2022)

Perception is in the Details: A Predictive Coding Account of the Psychedelic Phenomenon

Pink-Hashkes, S., Van Rooij, I., Kwisthout, J. · CogSci (2017)

Effective connectivity changes in LSD-induced altered states of consciousness in humans

Preller, K. H., Razi, A., Zeidman, P. et al. · PNAS (2019)

Neural Mechanisms and Psychology of Psychedelic Ego Dissolution

Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)

LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking

Wießner, I., Falchi, M., Maia, L. O. et al. · Journal of Psychopharmacology (2022)

32 cited

Cited By (6)

Papers in Blossom that reference this study

Neural mechanisms of psychedelic visual imagery

Stoliker, D., Preller, K. H., Novelli, L. et al. · Molecular Psychiatry (2024)

LSD microdosing attenuates the impact of temporal priors in time perception

Sadibolova, R., Murray-Lawson, C., Family, N. et al. · Biorxiv (2023)

Neural Mechanisms and Psychology of Psychedelic Ego Dissolution

Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)

Pattern Breaking: A Complex Systems Approach to Psychedelic Medicine

Hipólito, I., Mago, J., Rosas, F. E. et al. · Psyarxiv (2022)

Effective Connectivity of LSD-induced Ego Dissolution

Stoliker, D., Novelli, L., Vollenweider, F. X. et al. · MedRvix (2021)

4 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.